Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Urszula McClurg

Newcastle AuthorsTitleYearFull text
Dr Urszula McClurg
Svitlana Korolchuk
Dr Stuart McCracken
Dr Rakesh Heer
Laura Wilson
et al.
Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein2018
Dr Urszula McClurg
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Dr Stuart McCracken
Professor Craig Robson
et al.
Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP122018
Dr Urszula McClurg
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Professor Craig Robson
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival2018
Dr Urszula McClurg
Dr David Cork
Dr Steven Darby
Claudia Ryan-Munden
Dr Sirintra Nakjang
et al.
Identification of a novel K311 ubiquitination site critical for androgen receptor transcriptional activity2017
Dr Urszula McClurg
Dr Olivier Binda
ING3 promotes prostate cancer growth by activating the androgen receptor.2017
Dr Jennifer Munkley
Dr Urszula McClurg
Karen Livermore
Dr Ingrid Ehrmann
Professor Craig Robson
et al.
The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration2017
Dr Urszula McClurg
Dr Sirintra Nakjang
Dr Stuart McCracken
Professor Craig Robson
A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival2016
Dr Urszula McClurg
Dr Olivier Binda
Professor Craig Robson
Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 32016
Dr Ian Logan
Dr Urszula McClurg
Dr Dominic Jones
Daniel O'Neill
Dr Fadhel Shaheen
et al.
Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells2016
Dr Urszula McClurg
Professor Craig Robson
Deubiquitinating enzymes as oncotargets.2015
12